A dermatologic perspective on multisystem inflammatory syndrome in children.
Clin Dermatol
; 39(1): 163-168, 2021.
Article
in English
| MEDLINE | ID: covidwho-1300683
ABSTRACT
As of May 2020, an emerging immune-mediated syndrome mainly affecting children has been detected primarily in Europe and the United States. The incidence of this syndrome appears to mirror the initial infectious assault, with a delay of several weeks. This syndrome has been termed "multisystem inflammatory syndrome in children" (MIS-C) and is observed in association with the coronavirus disease 2019 (COVID-19). The phenotypes of presentation include several characteristic features, including prolonged fever, skin eruption, neck stiffness, and gastrointestinal manifestations with pronounced abdominal pain. Shock and organ dysfunction on presentation are frequent but inconsistent, whereas respiratory distress is typically and notably absent. We have reviewed recently published data aiming to better understand MIS-C, with a focus on its mucocutaneous manifestations.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Skin Diseases
/
Systemic Inflammatory Response Syndrome
/
COVID-19
Type of study:
Diagnostic study
/
Observational study
Topics:
Long Covid
Limits:
Adolescent
/
Child
/
Child, preschool
/
Humans
/
Infant
/
Infant, Newborn
Language:
English
Journal:
Clin Dermatol
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS